Oragenics (OGEN) Current Assets (2010 - 2026)
Oragenics' (OGEN) quarterly Current Assets came in at $7.5 million in Q1 2026, up 93.58% YoY from $3.9 million in Q1 2025, and down 25.61% on a QoQ basis from $10.1 million in Q4 2025.
Oragenics (OGEN) Current Assets (2010 - 2026) Analysis & Trends
Oragenics (OGEN) has 17 years of Current Assets data on file, last reported at $7.5 million in Q1 2026.
- Quarterly Current Assets rose 93.58% year-over-year to $7.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.5 million (up 93.58% YoY) and the FY2025 annual result came in at $10.1 million, up 583.71% from the prior year.
- Current Assets slipped to $7.5 million in Q1 2026, from $10.1 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $23.1 million in Q1 2022 to a low of $1.5 million in Q4 2024.
- A 5-year average of $8.9 million and a median of $7.8 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets slumped 80.01% — and 2025, when it soared 583.71%.
- Tracing OGEN's Current Assets over 5 years: stood at $14.3 million in 2022, then plunged by 72.95% to $3.9 million in 2023, then plunged by 61.91% to $1.5 million in 2024, then soared by 583.71% to $10.1 million in 2025, then declined by 25.61% to $7.5 million in 2026.
- The last three Current Assets figures came in at $7.5 million (Q1 2026), $10.1 million (Q4 2025), and $12.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 1.76 Bn |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - | 5.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.49 Mn |
| Mar 31, 2026 | 7.49 Mn |
| Dec 31, 2025 | 10.07 Mn |
| Sep 30, 2025 | 12.71 Mn |
| Jun 30, 2025 | 2.14 Mn |
| Mar 31, 2025 | 3.87 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Sep 30, 2024 | 4.11 Mn |
| Jun 30, 2024 | 1.62 Mn |
| Mar 31, 2024 | 2.44 Mn |
| Dec 31, 2023 | 3.87 Mn |
| Sep 30, 2023 | 7.81 Mn |
| Jun 30, 2023 | 8.10 Mn |
| Mar 31, 2023 | 11.70 Mn |
| Dec 31, 2022 | 14.29 Mn |
| Sep 30, 2022 | 16.52 Mn |
| Jun 30, 2022 | 19.86 Mn |
| Mar 31, 2022 | 23.09 Mn |
| Dec 31, 2021 | 27.71 Mn |
| Sep 30, 2021 | 30.54 Mn |